You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Prostate Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

Active, not recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +2 more
  • Fluorine F 18 rhPSMA-7.3
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Metastatic Prostate Cancer, Stage IIB Prostate Cancer, Stage IIC Prostate Cancer Trial in Philadelphia (Interview, Internet

Active, not recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +4 more
  • Interview
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Oct 25, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Circulating Tumor Cells in High Risk and Early Metastatic

Recruiting
  • High Risk Prostate Carcinoma
  • +3 more
  • Blood collection
  • Bala-Cynwyd, Pennsylvania
  • +1 more
Jun 28, 2022

Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium

Suspended
  • Prostate Adenocarcinoma
  • +2 more
  • Gallium Ga 68 DOTA-NeoBOMB1
  • Gallium Ga 68 PSMA-R2
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
May 3, 2022

Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed

Recruiting
  • Prostate Carcinoma
  • Recurrent Prostate Carcinoma
  • 99mTc-based PSMA Imaging and Surgery Agent
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Metastatic Malignant Tumor in the Prostate Gland, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles

Recruiting
  • Metastatic Malignant Neoplasm in the Prostate Gland
  • +2 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 18, 2022

Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma Trial in Duarte (procedure,

Recruiting
  • Localized Prostate Carcinoma
  • +17 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 1, 2023

Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

Serum Samples in Studying Emotional Stress in Prostate Cancer

Completed
  • Hormone-Resistant Prostate Cancer
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Mar 8, 2022

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Blood and Tissue Samples From Locally Recurrent or Metastatic

Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2021

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Atlanta, Georgia
  • +3 more
Mar 9, 2023

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +10 more
  • Radiation therapy
  • +2 more
  • Atlanta, Georgia
  • +3 more
Jun 7, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

Not yet recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Biospecimen Collection
  • +6 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 25, 2023

Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,

No longer available
  • Prostate Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jan 6, 2022

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography (CT) scan,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Computed Tomography (CT) scan
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 6, 2022